Deal 2: Lupin snaps up Temmler's products

Lupin has announced its second acquisition on the trot – this time an asset purchase deal concerning Temmler Pharma GmbH & Co's specialty product portfolio in Germany.

More from Musculoskeletal

More from Therapy Areas